The new research
The aim of the study is to demonstrate the performance of the neuCA15.3 test for monitoring treatment response and/or disease recurrence compared to an FDA cleared CA15-3 test (Roche Elecys CA15-3 II).
Is anyone expecting any significantly different data - we've already been told specificity and sensitivity %'s - what exactly will the new study tell us?
The new researchThe aim of the study is to demonstrate the...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
-0.020(3.85%) |
Mkt cap ! $46.00M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 52.0¢ | 50.0¢ | $28.57K | 56.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 11469 | 50.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.0¢ | 3333 | 1 |
View Market Depth
| Last trade - 15.46pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
50.5¢ |
Change
-0.020 ( 2.88 %) |
||||
| Open | High | Low | Volume | ||
| 50.5¢ | 50.5¢ | 50.5¢ | 7517 | ||
| Last updated 11.42am 16/05/2024 ? | |||||
| IIQ (ASX) Chart |